C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2002
11/28/2002	US20020177195 Production of human mutated proteins in human cells by means of homologous recombination
11/28/2002	US20020177191 Compound for use inthe diagnosis and treatment of cancer, viral, asthmatic, autoimmune, organ transplant rejection and infections
11/28/2002	US20020177189 Novel fluorescent proteins
11/28/2002	US20020177188 IL-17 homologous polypeptides and therapeutic uses thereof
11/28/2002	US20020177187 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
11/28/2002	US20020177185 Production of adenine nucleotide translocator (ant), novel ant lgands and screening assays therrfor
11/28/2002	US20020177176 Novel antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions
11/28/2002	US20020177165 Secreted and transmembrane polypeptides and nucleic acids encoding
11/28/2002	US20020177164 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/28/2002	US20020177155 Normalized nucleic acid libraries and methods of production thereof
11/28/2002	US20020177145 Detection and classification of nervous system progenitor cells; obtain tissue, monitor expression of daedalos protein in sample, compare to control, ampified daedalos expression indicates presence of nervous system progenitor cells
11/28/2002	US20020177142 Amplification of preferfetial nucleotide sequences; obtain nucleotide sequences, incubate with endonuclease, digest nucleotide sequences, amplifiy nucleotide sequences
11/28/2002	US20020177128 Variant of LAV viruses
11/28/2002	US20020177125 Polypeptide for use in the treatment of viral disease
11/28/2002	US20020177124 Nucleotide sequences coding polypeptide for use in the detection, prevention and diagnosis viral diseases
11/28/2002	US20020177121 Three-dimensional ex vivo angiogenesis system
11/28/2002	US20020177119 Cryopreservation system with controlled dendritic freezing front velocity
11/28/2002	US20020177117 Hyperbaric oxygen organ preservation system (hoops)
11/28/2002	US20020177116 Compositions and methods for the preservation of living tissues
11/28/2002	US20020176864 Two-domain MHC polypeptides include MHC( major histocompatibility complex) class II-based molecules that covalently linked beta 1 and alpha 1 domains, and MHC class I-based molecules that covalently linked alpha-1 and alpha-2
11/28/2002	US20020176859 Therapy of ototoxin- induced hearing impairments by administration of neurotrophins
11/28/2002	US20020176858 Monoclonal antibodies to TGF-BETA
11/28/2002	US20020176852 Mitogenic oxygenase regulators
11/28/2002	US20020176851 Aministering to mammal an effective amount of therapeutic cells, expressing a membrane-bound, proteinaceous chimeric receptor, capable recognizing and binding target cell or infective agent; antitumor therapy
11/28/2002	US20020176850 Immunotherapy of cancer with allogeneic lymphocytes
11/28/2002	DE10123958A1 Identifying ligands for G protein-coupled receptors, useful for treating cardiovascular disease, by using calcium-sensitive fluorophores in cells expressing G alpha proteins
11/28/2002	DE10122140A1 Rekombinante Fusionsproteine und deren Trimere Recombinant fusion proteins and their trimers
11/28/2002	CA2450677A1 A novel intein and uses thereof
11/28/2002	CA2448668A1 Modulation of cd200 receptors
11/28/2002	CA2448505A1 Compositions and methods for use in isolation of nucleic acid molecules
11/28/2002	CA2448386A1 Method of lift-off microstructuring deposition material on a substrate, substrates obtainable by the method, and use thereof
11/28/2002	CA2448360A1 Modulation of cell division by an early mitotic inhibitor protein
11/28/2002	CA2448145A1 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides
11/28/2002	CA2448132A1 Vectors for enhanced expression of vegf for disease treatment
11/28/2002	CA2448120A1 Muscle-specific expression vectors
11/28/2002	CA2448102A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002	CA2448097A1 N4 virion single-stranded dna dependent rna polymerase
11/28/2002	CA2448092A1 Internalisation of virus into cells
11/28/2002	CA2447958A1 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002	CA2447799A1 Emission ratiometric indicators of phosphorylation
11/28/2002	CA2447680A1 Hevein-binding monoclonal antibodies
11/28/2002	CA2447616A1 Vaccine composition
11/28/2002	CA2447340A1 Kinases and phosphatases
11/28/2002	CA2447338A1 Receptors and membrane-associated proteins
11/28/2002	CA2447313A1 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002	CA2447066A1 Method of treatment for cancers associated with elevated
11/28/2002	CA2446398A1 Nucleic acid and protein sequences of bovine epidermal growth factor
11/28/2002	CA2445972A1 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002	CA2444955A1 Inactivation of genes of the mep pathway
11/28/2002	CA2443437A1 Antibodies specific for cd44v6
11/28/2002	CA2443342A1 Mage-a3 peptides presented by hla class ii molecules
11/28/2002	CA2441666A1 Phytases, nucleic acids encoding them and methods and using them
11/27/2002	WO2001094575A1 Dna sequence regulating plant fruit-specific expression
11/27/2002	EP1260863A1 Micropatterning of plasma polymerized coatings
11/27/2002	EP1260587A2 Tyrosyl tRNA synthetase
11/27/2002	EP1260581A1 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
11/27/2002	EP1260580A1 Cell culture tube and multiple roller tube cell culture system using the same
11/27/2002	EP1260519A1 Membrane receptors for steroids and sterols
11/27/2002	EP1260228A2 Human growth gene and short stature gene region. Therapeutic uses
11/27/2002	EP1259824A1 Trisomy 21 cytotrophoblast cultures, and uses thereof for obtaining trisomy 21 markers
11/27/2002	EP1259821A1 Method of identifying modulators of presenilin
11/27/2002	EP1259812A2 Breast, gastric and prostate cancer associated antigens and uses therefor
11/27/2002	EP1259808A2 Method for labeling individual cells
11/27/2002	EP1259650A2 Estrogen receptor alpha variants and methods of detection thereof
11/27/2002	EP1259642A1 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259634A2 Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor
11/27/2002	EP1259626A2 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
11/27/2002	EP1259621A2 Lipid metabolism enzymes
11/27/2002	EP1259618A2 Human enzyme molecules
11/27/2002	EP1259616A2 Tnf-alpha variants for the treatment of tnf-alpha related disorders
11/27/2002	EP1259615A1 Human antibodies against eotaxin and their use
11/27/2002	EP1259614A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2002	EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002	EP1259611A2 G-protein coupled receptors
11/27/2002	EP1259609A2 Human schizophrenia gene
11/27/2002	EP1259608A1 Modified fluorescent proteins
11/27/2002	EP1259606A2 Compositions useful for regulating parkin gene activity
11/27/2002	EP1259605A2 Mutated cyclin g1 protein
11/27/2002	EP1259598A2 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/27/2002	EP1259593A1 Tooth progenitor cell and method for its production
11/27/2002	EP1259592A1 Monocyte-derived dendritic cell subsets
11/27/2002	EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002	EP1259542A2 Reagents and methods useful for detecting diseases of the breast
11/27/2002	EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/27/2002	EP1259540A1 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259531A2 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259530A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/27/2002	EP1259529A2 Thermophilic dna polymerases from thermoactinomyces vulgaris
11/27/2002	EP1259527A1 35 human secreted proteins
11/27/2002	EP1259526A2 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259525A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
11/27/2002	EP1259264A2 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
11/27/2002	EP1259253A2 Methods for promoting production of myelin by schwann cells
11/27/2002	EP1259251A2 Novel method for down-regulation of amyloid
11/27/2002	EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002	EP1059931B1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
11/27/2002	EP1019504A4 Isoforms of the human vitamin d receptor
11/27/2002	EP0938551A4 Ku DEFICIENT CELLS AND NON-HUMAN TRANSGENIC ANIMALS
11/27/2002	EP0804210B1 Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells
11/27/2002	EP0608261B1 Immunoreactive hepatitis c virus polypeptide compositions

1 ... 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 ... 1827